Applications
Designed for chronic disease decisions that unfold over time.
BioTraject Systems is developing computational decision systems for settings where progression, treatment response, acute instability, competing risks, and decision timing matter.
- Clinical care
- Health systems
- Research and evidence
- Life sciences
Four application areas
The same architecture supports different decisions across care, populations, research, and industry.
Clinical care
Support a clearer understanding of how disease is changing — organizing longitudinal measurements, treatments, diagnoses, and events into a structured view of trajectory, drivers, monitoring needs, uncertainty, and next questions.
Health systems
Make changing trajectories more visible across populations — patient identification, earlier recognition of worsening patterns, workflow prioritization, care coordination, and pathway evaluation.
Research and evidence
Study disease as a changing process — longitudinal characterization, trajectory phenotyping, patient heterogeneity, outcome forecasting, treatment-response modeling, study design, and real-world evidence.
Life sciences
Understand progression, heterogeneity, and treatment response over time — progression modeling, cohort characterization, stratification, treatment-response analysis, trial-design support, and post-market evaluation.
In clinical care, BioTraject can:
- Recognize patterns that may reflect persistent progression, short-term instability, treatment response, or recovery.
- Focus attention on monitoring needs, modifiable drivers, and unresolved clinical questions.
- Support better-timed reassessment, repeat testing, escalation, or specialist involvement.
The technology must adapt to the decision — not the other way around.
The same output should not automatically be used in the same way across clinical care, population health, research, and life sciences. Each application requires its own users, data, performance expectations, workflow, validation, governance, and intended-use boundaries.
Starting with chronic kidney disease.
NephroSync™ is the current application of BioTraject. It is being developed for kidney-care, health-system, research, and evidence-generation settings. Future disease-specific applications will require their own clinical knowledge, data, development, evaluation, safeguards, and intended-use definition.
Build and evaluate real-world applications with us.
BioTraject welcomes clinical, health-system, research, data, technology, life-sciences, and strategic partners interested in validation, pilot evaluation, workflow design, data integration, evidence generation, implementation planning, and responsible commercialization.
